ZBNA
WST icon

Zions Bancorporation, National Association’s West Pharmaceutical WST Stock Holding History

Zions Bancorporation, National Association’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.1K Buy
159
+10
+7% +$3.06K ﹤0.01% 536
2026
Q1 		$37.3K Sell
149
-163
-52% -$40.6K ﹤0.01% 596
2025
Q4 		$85.8K Buy
312
+63
+25% +$17.2K ﹤0.01% 537
2025
Q3 		$65.3K Buy
249
+80
+47% +$19.4K ﹤0.01% 519
2025
Q2 		$37K Buy
169
+58
+52% +$12.4K ﹤0.01% 568
2025
Q1 		$24.9K Buy
+111
New +$30.6K ﹤0.01% 612

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Zions Bancorporation, National Association's WST Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its West Pharmaceutical (WST) stake by 6.7% in Q2 2026, buying an estimated $3.06K and bringing the position to 159 shares worth $57.1K. The position accounts for ﹤0.01% of the portfolio, ranked #536.

Zions Bancorporation, National Association first reported a position in WST in Q1 2025 and has held it in 6 quarters since. The position peaked at $85.8K in Q4 2025. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Zions Bancorporation, National Association held 159 shares of West Pharmaceutical worth $57.1K as of Q2 2026.
  • Zions Bancorporation, National Association bought 10 West Pharmaceutical shares in Q2 2026, an estimated $3.06K.
  • West Pharmaceutical made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #536 holding.
  • Zions Bancorporation, National Association first reported a position in West Pharmaceutical in Q1 2025 and has held it in 6 quarters since.
  • Zions Bancorporation, National Association's West Pharmaceutical position peaked at $85.8K in Q4 2025.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.